Highlights Curexo Inc.

Equities

A060280

KR7060280005

End-of-day quote Korea S.E. Other stock markets 03:30:00 24/05/2024 am IST			5-day change	1st Jan Change
10,970 ^KRW	-4.02%		-7.11%	-41.05%

2022	Think Surgical, Inc. and Curexo Inc. Announces Entry into Development and Distribution Agreement	CI
2022	Curexo Inc. announced that it has received KRW 40.49999982 billion in funding from L&C Bio Co., Ltd	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Think Surgical, Inc. and Curexo Inc. Announces Entry into Development and Distribution Agreement	01/22/01	CI
CUREXO Corp. Spinal Surgery Robot, 'Cuvis-Spine' Acquires FDA (US) Licensing	22/21/22	CI
Bionik Laboratories Corp. Enters into a Distribution Agreement with Curexo Inc	29/20/29	CI
Bionik Laboratories Corp. Enters into a Distribution Agreement with Curexo Inc	07/18/07	CI
Bionik Laboratories Corp. and Curexo Enter Exclusive Distribution Agreement for Sale of Robotic Rehabilitation Systems in U.S. and South Korea	07/18/07	CI
Curexo Inc. completed the acquisition of Medical Robotics Business from Hyundai Heavy Industries Co., Ltd..	08/17/08	CI
Curexo Inc. signed a term sheet to acquire Medical Robotics Business from Hyundai Heavy Industries Co., Ltd. for KRW 11.8 billion.	13/17/13	CI
Curexo Inc (KOSE: A060280) cancelled the acquisition of Samyoung System Co., Ltd.	12/12/12	CI
Daewon Media Co., Ltd completed the acquisition of Daiwaon Culture Industry Inc. Co., Ltd. from Curexo Inc.	26/12/26	CI
Daewon Media Co., Ltd completed the acquisition of Daiwon CI Inc. from Curexo Inc.	26/12/26	CI
Daewon Media Co., Ltd agreed to acquire Daiwaon Culture Industry Inc. Co., Ltd. from Curexo Inc for KRW 2.5 billion.	25/12/25	CI
Daewon Media Co., Ltd agreed to acquire Daiwon CI Inc. from Curexo Inc for KRW 2.5 billion.	25/12/25	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

+39.41% on our US portfolio vs. 25.67% on the S&P 500 net Total Return

Replicate our performance

fermer